The Aurum Institute Welcomes Prof. Vinodh Edward as Group Chief Operating Officer
The Aurum Institute Board is thrilled to announce Prof. Vinodh Edward's appointment as the new Group Chief Operating Officer (GCOO), effective 1 January 2025. This strategic move marks a significant
New Research Hub Launched to Study Health and Social Impact of Mining and Migration in Royal Bafokeng Nation
JOHANNESBURG, 27 November 2024. The BAMMISHO Node, or Bafokeng Health & Demographic Surveillance System (HDSS), has been officially launched as the latest South African Population Research Infrastructure Network (SAPRIN) site
The Aurum Institute Announces New Group CEO to Lead Next Phase of Growth
JOHANNESBURG, 26 August 2024. The Aurum Institute, a leading Africa-based global health organisation today announced that Professor Dave Clark will succeed Professor Gavin Churchyard as Group CEO, effective Jan. 1, 2025. Prof
USAID-Funded ACCELERATE Initiative to Boost Tuberculosis Elimination Efforts in South Africa
In a landmark move towards ending tuberculosis (TB) in South Africa, the U.S. Agency for International Development (USAID) has awarded the Aurum Institute US $47 million (approx. R886 million) to
New Study: Combo Treatment Can Help Solve the TB-HIV Co-Infection Crisis — More than Half a Million People Could Benefit
For people starting HIV treatment, combining dolutegravir-containing antiretroviral therapy with 3HP TB preventive treatment is safe and works effectively in tandem
DENVER (March 5, 2023) — New clinical trial
New Child-Friendly Formulation of Rifapentine for Short Course Tuberculosis Prevention Treatment.
Now Available as Unitaid and IMPAACT4TB Launch an Early Market Access Vehicle (EMAV)
More than 2 million children and adolescents lack preventive treatment for TB, which is needed for those
